Lower corticosteroid skin blanching response is associated with severe COPD

Area of Science:

• Pulmonary Medicine
• Dermatology
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) involves airway inflammation and remodeling, often poorly responsive to corticosteroids.
• Understanding the mechanisms of corticosteroid insensitivity in COPD is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the association between skin corticosteroid insensitivity and the severity of COPD.
• To utilize the corticosteroid skin blanching test to assess this relationship.

Main Methods:

• Included COPD patients (GOLD stages I-IV) and healthy never-smokers and smokers.
• Assessed corticosteroid sensitivity using the corticosteroid skin blanching test with varying budesonide concentrations.
• Measured spirometry and body plethysmography in all participants.

Main Results:

• GOLD III and IV COPD patients demonstrated significantly lower skin blanching responses compared to healthy individuals and GOLD I/II patients.
• Lower FEV1 and higher RV/TLC ratios correlated with reduced skin blanching responses.
• Age and pack-years were comparable across all GOLD stages.

Conclusions:

• Severe COPD patients exhibit decreased skin corticosteroid sensitivity compared to mild/moderate COPD patients and controls.
• This reduced skin blanching response may indicate a specific COPD subgroup with an early-onset phenotype.